Omeros Corp (OMER) Stock Price & News - Google Finance (2024)








FTSE 1008,194.82+0.59%+47.79FTSE 1008,194.820.59%
CAC 408,049.78-0.19%-15.37CAC 408,049.780.19%
IBEX 3510,928.00-1.56%-172.80IBEX 3510,928.001.56%
STOXX 504,957.85-0.47%-23.24STOXX 504,957.850.47%


Omeros Corp


After Hours:



Closed: Apr 29, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Theravance Biopharma Inc



Harrow Inc



Trupanion Inc



Ardelyx Inc



Cara Therapeutics Inc



Nektar Therapeutics



Revance Therapeutics Inc



Cellectar Biosciences Inc



Ocular Therapeutix Inc



Perrigo Company PLC



In the news


Income Statement


Net income

(USD)Dec 2023info

Fiscal Q4 2023 ended 12/31/23. Reported on 4/1/24.

Y/Y change


The total amount of income generated by the sale of goods or services related to the company's primary operations

Operating expense

Represents the total incurred expenses through normal operations


Net income

Company’s earnings for a period net of operating costs, taxes, and interest


Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.



Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances


Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Dec 2023info

Fiscal Q4 2023 ended 12/31/23. Reported on 4/1/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year


Total assets

The total amount of assets owned by a company


Total liabilities

Sum of the combined debts a company owes


Total equity

The value of subtracting the total liabilities from the total assets of a company


Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing


Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock


Return on assets

A financial ratio that shows a company’s profitability compared to its assets


Return on capital

Company’s return above the average cost it pays for its debt and equity capital


Net change in cash

(USD)Dec 2023info

Fiscal Q4 2023 ended 12/31/23. Reported on 4/1/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest


Cash from operations

Net cash used or generated for core business activities

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments


Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on NASDAQ

US headquartered

Headquartered in Seattle, Washington, United States

Previous close

The last closing price


Day range

The range between the high and low prices over the past day

$3.11 - $3.31

Year range

The range between the high and low prices over the past 52 weeks

$0.92 - $7.80

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

181.36M USD

Avg Volume

The average number of shares traded each day over the past 30 days


P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks


Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock


Primary exchange

Listed exchange for this security






Seattle, WashingtonUnited States


Discover more

You may be interested in


This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexFTSE 100 Index8,194.820.59%
IndexDow Jones Industrial Average38,386.090.38%
IndexFTSE 250 Index20,079.390.027%
TSLATesla Inc$194.0515.31% Inc$180.960.75%
AAPLApple Inc$173.502.48%
LLOYLloyds Banking Group PLCGBX52.140.50%
BARCBarclays PLCGBX204.750.54%
BPBP plcGBX528.100.92%
IndexFTSE All-Share Index4,457.120.49%
IndexBSE SENSEX74,482.780.25%
RRRolls-Royce Holdings PLCGBX415.500.17%
BABAAlibaba Group Holding Ltd - ADR$76.411.14%
IAGInternational Consolidated Airlns Grp SAGBX175.401.02%
IndexNIFTY 5022,604.850.17%
EZJeasyJet plcGBX540.200.22%

People also search for

TBPHTheravance Biopharma Inc$8.991.43%
HROWHarrow Inc$10.620.85%
TRUPTrupanion Inc$24.000.50%
ARDXArdelyx Inc$6.460.62%
CARACara Therapeutics Inc$0.7610.40%
NKTRNektar Therapeutics$1.4610.61%
RVNCRevance Therapeutics Inc$3.698.53%
CLRBCellectar Biosciences Inc$3.102.31%
OCULOcular Therapeutix Inc$4.801.16%
PRGOPerrigo Company PLC$32.812.72%
CMRXChimerix Inc$0.933.86%
AKBAAkebia Therapeutics Inc$1.321.49%
MRNSMarinus Pharmaceuticals Inc$1.400.36%
RLMDRelmada Therapeutics Inc$3.537.83%
OVIDOvid Therapeutics Inc$3.347.74%
SCPHScpharmaceuticals Inc$4.582.00%
AVXLAnavex Life Sciences Corp$3.656.10%
ORMPOramed Pharmaceuticals, Inc.$2.441.02%

Omeros Corp (OMER) Stock Price & News - Google Finance (2)HelpSend feedbackPrivacyTermsDisclaimer

Omeros Corp (OMER) Stock Price & News - Google Finance (2024)


Top Articles
Latest Posts
Article information

Author: Greg O'Connell

Last Updated:

Views: 5822

Rating: 4.1 / 5 (42 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Greg O'Connell

Birthday: 1992-01-10

Address: Suite 517 2436 Jefferey Pass, Shanitaside, UT 27519

Phone: +2614651609714

Job: Education Developer

Hobby: Cooking, Gambling, Pottery, Shooting, Baseball, Singing, Snowboarding

Introduction: My name is Greg O'Connell, I am a delightful, colorful, talented, kind, lively, modern, tender person who loves writing and wants to share my knowledge and understanding with you.